CD19 and neoplasm: Diagnosis is primarily cytological, hinging on the classic “starry sky” appearance, alongside immunophenotyping that shows tumor cells positive for B‐cell markers (CD19, CD20, CD22, CD79a, CD38, PAX5) and germinal‐center markers (CD10, BCL6).